Urology · Carmel, IN
NPI
1447264676
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
11380 Illinois St
Carmel, IN, 46032
Phone (317) 890-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$762K
15,942 services
Medicare patients, 2024
670
Average age 75
Drug cost, 2024
$5.7M
1,732 prescriptions
Company payments, 2025
$1,167
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott B Farnham was code J0897 (injection, denosumab, 1 mg), 5,820 times for 35 patients. In total Scott B Farnham billed 15,942 services in 109 codes, and Medicare paid $762K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,820 | 35 | $20.54 | $120K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,885 | 55 | $0.10 | $506 |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,386 | 32 | $43.36 | $60K |
| 99213 Office E&M - Established | Office | 385 | 302 | $56.07 | $22K |
| 99214 Office E&M - Established | Office | 349 | 234 | $85.65 | $30K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 285 | 48 | $138.77 | $40K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 244 | 192 | $11.31 | $2,760 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 236 | 34 | $42.57 | $10K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 131 | 15 | $44.86 | $5,876 |
| 96402 Chemotherapy Administration | Office | 120 | 54 | $23.04 | $2,765 |
| 36415 Venipuncture Blood Collection | Office | 114 | 101 | $8.59 | $979 |
| 96372 Injection Administration | Office | 65 | 39 | $9.74 | $633 |
| 99215 Office E&M - Established | Office | 64 | 54 | $125.87 | $8,056 |
| 52000 Cystourethroscopy | Office | 54 | 49 | $163.09 | $8,807 |
| 99204 Office E&M - New | Office | 46 | 46 | $111.09 | $5,110 |
By year: 2022 $465K for 14,599 services; 2023 $356K for 13,391 services; 2024 $762K for 15,942 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 114 | 101 | $8.59 | $979 |
| 81003 Clinical Chemistry | 35 | 29 | $2.20 | $77 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott B Farnham prescribed most often to Medicare patients was Tamsulosin Hcl, with 377 prescriptions and refills. In total Scott B Farnham wrote 1,732 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 377 | 953 | 121 | $6,234 |
| Erleada Apalutamide | 260 | 262 | 37 | $3.8M |
| Finasteride Generic | 181 | 541 | 57 | $2,278 |
| Duloxetine Hcl Generic | 133 | 250 | 30 | $2,454 |
| Orgovyx Relugolix | 94 | 95 | 18 | $250K |
| Prednisone Generic | 89 | 121 | 20 | $651 |
| Abiraterone Acetate Generic | 69 | 97 | 14 | $134K |
| Nubeqa Darolutamide | 68 | 68 | Under 11 | $870K |
| Xtandi Enzalutamide | 48 | 49 | Under 11 | $500K |
| Myrbetriq Mirabegron | 47 | 85 | 13 | $38K |
| Gemtesa Vibegron | 38 | 60 | Under 11 | $30K |
| Megestrol Acetate Generic | 34 | 46 | Under 11 | $422 |
| Potassium Citrate Er Potassium Citrate | 33 | 92 | 12 | $3,546 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 30 | 30 | 29 | $170 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 24 | 67 | 11 | $670 |
Brand drugs: 581 claims; generic drugs: 1,151 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott B Farnham $1,167 ($1,167 in general payments such as food, travel and fees) from 19 companies. The largest payer was Sumitomo Pharma America, Inc. with $179.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 7 | $179 |
| Dendreon Pharmaceuticals LLC | 7 | $171 |
| Accord Healthcare, Inc. | 5 | $129 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $111 |
| Pfizer Inc. PFE | 6 | $111 |
| Merck Sharp & Dohme LLC MRK | 3 | $69.43 |
| Endo USA, Inc. | 3 | $62.76 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $50.52 |
| Progenics Pharmaceuticals, Inc. | 2 | $41.38 |
| CIVCO Medical Instruments | 1 | $40.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.